ZENTEL 400 mg, tablet tablet
Active ingredients: Albendazol
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Tablettabletorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- ZENTEL 400 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 1 comprimé(s)
- Marketing authorisation holder
- GLAXOSMITHKLINE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Mar 2006
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65565944CIP73684826CIP133400936848269Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALBENDAZOLEcomprimé | 400 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.